US2017136066A1PendingUtilityA1

Methods of using regenerative cells in the treatment of renal diseases and disorders

60
Assignee: CYTORI THERAPEUTICS INCPriority: Dec 7, 2001Filed: Nov 28, 2016Published: May 18, 2017
Est. expiryDec 7, 2021(expired)· nominal 20-yr term from priority
A61K 35/28A61K 35/35A61L 2300/416A61M 2202/0437A61L 27/54A61L 27/3886A61K 35/22A61L 2300/414A61M 1/3696A61K 35/44A61L 2430/26A61M 2202/08A61M 1/3692C12N 5/0667A61M 1/3693A61L 27/3834
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Cells present in processed lipoaspirate tissue are used to treat patients, including patients with renal conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in processed lipoaspirate are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic renal benefit.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating impaired renal function in a patient, comprising:
 identifying a patient with impaired renal function; and   providing to the patient's renal vasculature an amount of a concentrated population of cells comprising adipose-derived stem cells sufficient to improve function of the kidney of said patient.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.